Stapling is a key technique for stabilising peptides in an α-helical structure. The resultant stapled peptides are then able to compete efficiently for binding to protein targets involved in protein–protein interactions that are mediated by α-helices. Certain general design principles to optimise their binding and biological activity have emerged in recent years. This is accompanied by an increasing use of computational methods in stapled peptide design.
The stapling technique is rapidly emerging as one of the most widely adopted strategies for α-helix stabilisation. Stapled peptides are highly promising therapeutic agents for the inhibition of PPIs, because they generally exhibit enhanced helicity, protease resistance, and biological potency. The development of stapled peptides promises to enable access to α-helix-mediated PPI drug targets. It has also been shown that stapled peptides are able to disrupt enzyme, multidrug resistance efflux pump and membrane receptor dimers, thus opening up new possibilities for targeting traditional drug targets, which is becoming especially important because of the development of resistance against current drugs.